{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:18:50Z","timestamp":1791897530989,"version":"4.3.4"},"reference-count":67,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.mcna.2025.11.010","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T21:38:24Z","timestamp":1770241104000},"page":"481-499","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Perioperative Medication Management for Patients with Diabetes"],"prefix":"10.1016","volume":"110","author":[{"given":"Elizabeth W.","family":"Duggan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. David","family":"Mazer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.mcna.2025.11.010_bib2","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1111\/dom.13830","article-title":"Treatment patterns and associated factors in 14 668 people with type 2 diabetes initiating a second-line therapy: results from the global DISCOVER study programme","volume":"21","author":"Nicolucci","year":"2019","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.mcna.2025.11.010_bib3","unstructured":"World Health Organization. The selection and use of essential medicines, 2025: WHO Model List of Essential Medicines, 24th list. Accessed October 15, 2025. 10.247\/B09474."},{"issue":"17","key":"10.1016\/j.mcna.2025.11.010_bib4","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1161\/CIRCULATIONAHA.118.038868","article-title":"Comparison of the effects of glucagon-like peptide receptor agonists and sodium-glucose cotransporter 2 inhibitors for prevention of major adverse cardiovascular and renal outcomes in type 2 diabetes mellitus","volume":"139","author":"Zelniker","year":"2019","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.mcna.2025.11.010_bib5","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1213\/ANE.0000000000006791","article-title":"Society for ambulatory anesthesia updated consensus statement on perioperative blood glucose management in adult patients with diabetes mellitus undergoing ambulatory surgery","volume":"139","author":"Rajan","year":"2024","journal-title":"Anesth Analg"},{"key":"10.1016\/j.mcna.2025.11.010_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.jclinane.2024.111627","article-title":"Perioperative management of adult patients with diabetes wearing devices: a society for perioperative assessment and quality improvement (SPAQI) expert consensus statement","volume":"99","author":"Oprea","year":"2024","journal-title":"J Clin Anesth"},{"issue":"6","key":"10.1016\/j.mcna.2025.11.010_bib7","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/ACO.0000000000001438","article-title":"Caring for patients with diabetes in the outpatient surgical setting: current recommendations and controversies","volume":"37","author":"Duggan","year":"2024","journal-title":"Curr Opin Anaesthesiol"},{"issue":"8","key":"10.1016\/j.mcna.2025.11.010_bib8","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s40261-019-00799-0","article-title":"Emerging trends in metformin prescribing in the United States from 2000 to 2015","volume":"39","author":"Le","year":"2019","journal-title":"Clin Drug Invest"},{"issue":"3","key":"10.1016\/j.mcna.2025.11.010_bib9","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/dom.13118","article-title":"Peri-operative continuation of metformin does not improve glycaemic control in patients with type 2 diabetes: a randomized controlled trial","volume":"20","author":"Hulst","year":"2018","journal-title":"Diabetes Obes Metabol"},{"issue":"1","key":"10.1016\/j.mcna.2025.11.010_bib10","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1213\/01.ane.0000242532.42656.e7","article-title":"Recent metformin ingestion does not increase in-hospital morbidity or mortality after cardiac surgery","volume":"104","author":"Duncan","year":"2007","journal-title":"Anesth Analg"},{"issue":"2","key":"10.1016\/j.mcna.2025.11.010_bib11","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/ALN.0000000000003237","article-title":"Perioperative management of oral glucose-lowering drugs in the patient with type 2 diabetes","volume":"133","author":"Preiser","year":"2020","journal-title":"Anesthesiology"},{"issue":"1 Suppl 1","key":"10.1016\/j.mcna.2025.11.010_bib12","first-page":"S321","article-title":"Diabetes care in the hospital: standards of care in Diabetes-2025","volume":"48","year":"2025","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.mcna.2025.11.010_bib13","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1213\/ANE.0000000000003675","article-title":"Preoperative continuation versus interruption of oral hypoglycemics in type 2 diabetic patients undergoing ambulatory surgery: a randomized controlled trial","volume":"127","author":"Gasanova","year":"2018","journal-title":"Anesth Analg"},{"issue":"1 Suppl 1","key":"10.1016\/j.mcna.2025.11.010_bib14","first-page":"S181","article-title":"Pharmacologic approaches to glycemic treatment: standards of care in Diabetes-2025","volume":"48","year":"2025","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.mcna.2025.11.010_bib15","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.19099","article-title":"Association of cumulative multimorbidity, glycemic control, and medication use with hypoglycemia-related emergency department visits and hospitalizations among adults with diabetes","volume":"3","author":"McCoy","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.mcna.2025.11.010_bib16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.bja.2019.03.028","article-title":"Perioperative diabetic ketoacidosis associated with sodium-glucose co-transporter-2 inhibitors: a systematic review","volume":"123","author":"Thiruvenkatarajan","year":"2019","journal-title":"Br J Anaesth"},{"issue":"9","key":"10.1016\/j.mcna.2025.11.010_bib17","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.2337\/dc15-0843","article-title":"Euglycemic diabetic ketoacidosis: a potential complication of treatment with sodium-glucose cotransporter 2 inhibition","volume":"38","author":"Peters","year":"2015","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.mcna.2025.11.010_bib18","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.bjae.2024.04.007","article-title":"Update on the perioperative management of diabetes mellitus","volume":"24","author":"Polderman","year":"2024","journal-title":"BJA Educ"},{"issue":"9","key":"10.1016\/j.mcna.2025.11.010_bib20","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.eprac.2022.06.006","article-title":"Inpatient perioperative euglycemic diabetic ketoacidosis due to sodium-glucose Cotransporter-2 inhibitors - lessons from a case series and strategies to decrease incidence","volume":"28","author":"Mehta","year":"2022","journal-title":"Endocr Pract"},{"issue":"2","key":"10.1016\/j.mcna.2025.11.010_bib21","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/EJA.0000000000002090","article-title":"Metabolic acidosis in patients with diabetes 2 undergoing cardiac surgery: the impact of SGLT2 inhibitor use: a retrospective cohort study","volume":"42","author":"Brekke","year":"2025","journal-title":"Eur J Anaesthesiol"},{"issue":"3","key":"10.1016\/j.mcna.2025.11.010_bib22","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00540-023-03174-8","article-title":"Sodium-glucose cotransporter 2 inhibitor-associated perioperative ketoacidosis: a systematic review of case reports","volume":"37","author":"Seki","year":"2023","journal-title":"J Anesth"},{"issue":"2","key":"10.1016\/j.mcna.2025.11.010_bib23","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.bja.2023.11.015","article-title":"Sodium-glucose cotransporter-2 inhibitors in non-diabetic patients: is there a perioperative risk of euglycaemic ketoacidosis","volume":"132","author":"Ruste","year":"2024","journal-title":"Br J Anaesth"},{"issue":"3","key":"10.1016\/j.mcna.2025.11.010_bib24","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/03007995.2025.2458538","article-title":"Perioperative and periprocedural management of GLP-1 receptor-based agonists and SGLT2 inhibitors: narrative review and the STOP-GAP and STOP DKA-2 algorithms","volume":"41","author":"Goldenberg","year":"2025","journal-title":"Curr Med Res Opin"},{"issue":"39","key":"10.1016\/j.mcna.2025.11.010_bib25","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1093\/eurheartj\/ehac270","article-title":"2022 ESC guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery","volume":"43","author":"Halvorsen","year":"2022","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.mcna.2025.11.010_bib27","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/anae.16541","volume":"80","author":"El-Boghdadly","year":"2025","journal-title":"Anaesthesia"},{"issue":"12","key":"10.1016\/j.mcna.2025.11.010_bib30","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1111\/anae.13233","article-title":"Peri-operative management of the surgical patient with diabetes 2015: Association of Anaesthetists of Great Britain and Ireland","volume":"70","author":"Membership of the Working","year":"2015","journal-title":"Anaesthesia"},{"issue":"2","key":"10.1016\/j.mcna.2025.11.010_bib31","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S2213-8587(16)30402-8","article-title":"Efficacy of sitagliptin for the hospital management of general medicine and surgery patients with type 2 diabetes (Sita-Hospital): a multicentre, prospective, open-label, non-inferiority randomised trial","volume":"5","author":"Pasquel","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10","key":"10.1016\/j.mcna.2025.11.010_bib32","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1111\/dom.14100","article-title":"Ultra rapid lispro improves postprandial glucose control compared with lispro in patients with type 1 diabetes: results from the 26-week PRONTO-T1D study","volume":"22","author":"Klaff","year":"2020","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.mcna.2025.11.010_bib33","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jclinane.2016.10.003","article-title":"Effect of basal insulin dosage on blood glucose concentration in ambulatory surgery patients with type 2 diabetes","volume":"36","author":"Demma","year":"2017","journal-title":"J Clin Anesth"},{"issue":"8","key":"10.1016\/j.mcna.2025.11.010_bib34","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.jclinane.2012.02.010","article-title":"Insulin glargine dosing before next-day surgery: comparing three strategies","volume":"24","author":"Rosenblatt","year":"2012","journal-title":"J Clin Anesth"},{"issue":"2","key":"10.1016\/j.mcna.2025.11.010_bib35","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/dom.12032","article-title":"Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre-planned meta-analysis of phase 3 trials","volume":"15","author":"Ratner","year":"2013","journal-title":"Diabetes Obes Metabol"},{"issue":"5","key":"10.1016\/j.mcna.2025.11.010_bib36","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.eprac.2025.01.009","article-title":"Perioperative and periprocedural management of once-weekly insulin treated patients","volume":"31","author":"Houlden","year":"2025","journal-title":"Endocr Pract"},{"issue":"3","key":"10.1016\/j.mcna.2025.11.010_bib37","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/ALN.0000000000001515","article-title":"Perioperative hyperglycemia management: an update","volume":"126","author":"Duggan","year":"2017","journal-title":"Anesthesiology"},{"issue":"9","key":"10.1016\/j.mcna.2025.11.010_bib38","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1111\/dme.14304","volume":"37","author":"Dhatariya","year":"2020","journal-title":"Diabet Med"},{"issue":"6","key":"10.1016\/j.mcna.2025.11.010_bib39","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa2107519","article-title":"Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes","volume":"385","author":"Frias","year":"2021","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.mcna.2025.11.010_bib40","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1056\/NEJMc2410532","article-title":"Semaglutide for chronic kidney disease in type 2 diabetes. Reply","volume":"391","author":"Perkovic","year":"2024","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.mcna.2025.11.010_bib41","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2403347","article-title":"Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes","volume":"391","author":"Perkovic","year":"2024","journal-title":"N Engl J Med"},{"issue":"10402","key":"10.1016\/j.mcna.2025.11.010_bib42","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0140-6736(23)01200-X","article-title":"Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial","volume":"402","author":"Garvey","year":"2023","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.mcna.2025.11.010_bib44","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.soard.2024.08.033","article-title":"Multisociety clinical practice guidance for the safe use of glucagon-like peptide-1 receptor agonists in the perioperative period","volume":"20","author":"Kindel","year":"2024","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.mcna.2025.11.010_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.jclinane.2025.111853","article-title":"Ultrasound assessment of preoperative gastric volume in fasted diabetic surgical patients: a prospective observational cohort study on the effects of glucagon-like peptide-1 agonists on gastric emptying","volume":"104","author":"Wolla","year":"2025","journal-title":"J Clin Anesth"},{"issue":"4","key":"10.1016\/j.mcna.2025.11.010_bib47","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.gie.2024.04.2900","article-title":"Effects of glucagon-like peptide-1 receptor agonists on upper endoscopy in diabetic and nondiabetic patients","volume":"100","author":"Nadeem","year":"2024","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.mcna.2025.11.010_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.jclinane.2023.111091","article-title":"Relationship between perioperative semaglutide use and residual gastric content: a retrospective analysis of patients undergoing elective upper endoscopy","volume":"87","author":"Silveira","year":"2023","journal-title":"J Clin Anesth"},{"issue":"5","key":"10.1016\/j.mcna.2025.11.010_bib49","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.cgh.2024.03.013","article-title":"Clinical outcomes and safety of upper endoscopy while on glucagon-like Peptide-1 receptor agonists","volume":"23","author":"Firkins","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.mcna.2025.11.010_bib50","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.14309\/ajg.0000000000002777","article-title":"Glucagon-like Peptide-1 receptor agonists increase solid gastric residue rates on upper endoscopy especially in patients with complicated diabetes: a case-control study","volume":"119","author":"Garza","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.mcna.2025.11.010_bib51","article-title":"Assessment of gastric content using gastric ultrasound in patients on glucagon-like Peptide-1 receptor agonists before anesthesia","author":"Pai","year":"2025","journal-title":"Anesth Analg"},{"issue":"9","key":"10.1016\/j.mcna.2025.11.010_bib52","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvaf088","article-title":"Glucagon-like Peptide-1 receptor agonists and peri-procedural aspiration risk","volume":"9","author":"Ho","year":"2025","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.mcna.2025.11.010_bib53","article-title":"Risk of perioperative cardiorespiratory complications and mortality associated with preoperative glucagon-like peptide-1 receptor agonist use in type 2 diabetes mellitus: a nationwide propensity-score matched study","author":"Wu","year":"2025","journal-title":"Br J Anaesth"},{"issue":"3","key":"10.1016\/j.mcna.2025.11.010_bib54","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.0081","article-title":"Postoperative aspiration pneumonia among adults using GLP-1 receptor agonists","volume":"8","author":"Chen","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"5","key":"10.1016\/j.mcna.2025.11.010_bib55","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.cgh.2024.07.021","article-title":"Effects of glucagon-like Peptide-1 receptor agonists on upper gastrointestinal endoscopy: a meta-analysis","volume":"23","author":"Facciorusso","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.mcna.2025.11.010_bib56","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1001\/jamasurg.2024.0111","article-title":"Glucagon-like Peptide-1 receptor agonist use and residual gastric content before anesthesia","volume":"159","author":"Sen","year":"2024","journal-title":"JAMA Surg"},{"issue":"5","key":"10.1016\/j.mcna.2025.11.010_bib57","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1111\/dom.13633","article-title":"Effects of lixisenatide on postprandial blood pressure, gastric emptying and glycaemia in healthy people and people with type 2 diabetes","volume":"21","author":"Jones","year":"2019","journal-title":"Diabetes Obes Metabol"},{"issue":"4","key":"10.1016\/j.mcna.2025.11.010_bib58","doi-asserted-by":"crossref","first-page":"864","DOI":"10.2337\/dc22-2260","article-title":"Performance of the dexcom G6 continuous glucose monitoring system during cardiac surgery using hypothermic extracorporeal circulation","volume":"46","author":"Herzig","year":"2023","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.mcna.2025.11.010_bib59","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/ALN.0000000000005204","article-title":"Perioperative management of patients taking glucagon-like Peptide-1 receptor agonists: applying evidence to clinical practice","volume":"141","author":"Oprea","year":"2024","journal-title":"Anesthesiology"},{"issue":"1 Suppl 1","key":"10.1016\/j.mcna.2025.11.010_bib60","first-page":"S146","article-title":"Diabetes technology: standards of care in diabetes-2025","volume":"48","year":"2025","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.mcna.2025.11.010_bib62","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1213\/ANE.0000000000007115","article-title":"Perioperative care of patients using wearable diabetes devices","volume":"140","author":"Cruz","year":"2025","journal-title":"Anesth Analg"},{"issue":"2","key":"10.1016\/j.mcna.2025.11.010_bib63","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1177\/1932296819895505","article-title":"A head-to-head comparison study of the first-day performance of two factory-calibrated CGM systems","volume":"14","author":"Denham","year":"2020","journal-title":"J Diabetes Sci Technol"},{"issue":"14","key":"10.1016\/j.mcna.2025.11.010_bib64","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJMoa0805017","article-title":"Continuous glucose monitoring and intensive treatment of type 1 diabetes","volume":"359","author":"Tamborlane","year":"2008","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.mcna.2025.11.010_bib65","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1001\/jama.2016.19975","article-title":"Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the DIAMOND randomized clinical trial","volume":"317","author":"Beck","year":"2017","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.mcna.2025.11.010_bib66","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1089\/dia.2023.0390","article-title":"Continuous glucose monitoring systems in noninsulin-treated people with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials","volume":"26","author":"Ferreira","year":"2024","journal-title":"Diabetes Technol Therapeut"},{"issue":"1","key":"10.1016\/j.mcna.2025.11.010_bib67","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1089\/dia.2021.0212","article-title":"Use of real-time continuous glucose monitoring improves glycemic control and other clinical outcomes in type 2 diabetes patients treated with less intensive therapy","volume":"24","author":"Grace","year":"2022","journal-title":"Diabetes Technol Therapeut"},{"issue":"4","key":"10.1016\/j.mcna.2025.11.010_bib68","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1177\/19322968241271304","article-title":"FDA interoperability designation-creating options for people with diabetes and pump companies: regulatory, technological, and commercial perspectives","volume":"19","author":"Klonoff","year":"2025","journal-title":"J Diabetes Sci Technol"},{"issue":"5","key":"10.1016\/j.mcna.2025.11.010_bib69","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1177\/19322968231156572","article-title":"Interruption of continuous glucose monitoring: frequency and adverse consequences","volume":"18","author":"Markov","year":"2024","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.mcna.2025.11.010_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.bja.2025.05.057","article-title":"Accuracy of continuous glucose monitoring during noncardiac surgery: a prospective, blinded observational multicentre cohort study","author":"Janssen","year":"2025","journal-title":"Br J Anaesth"},{"issue":"18","key":"10.1016\/j.mcna.2025.11.010_bib71","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1056\/NEJMoa1907863","article-title":"Six-month randomized, multicenter trial of closed-loop control in type 1 diabetes","volume":"381","author":"Brown","year":"2019","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.mcna.2025.11.010_bib72","doi-asserted-by":"crossref","first-page":"607","DOI":"10.2337\/dc19-1310","article-title":"Randomized controlled trial of Mobile closed-loop control","volume":"43","author":"Kovatchev","year":"2020","journal-title":"Diabetes Care"},{"issue":"S3","key":"10.1016\/j.mcna.2025.11.010_bib73","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1089\/dia.2023.0442","article-title":"Real-world evidence of automated insulin delivery system use","volume":"26","author":"Considine","year":"2024","journal-title":"Diabetes Technol Therapeut"},{"issue":"5","key":"10.1016\/j.mcna.2025.11.010_bib74","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1111\/dom.15462","article-title":"The use of an automated insulin delivery system is associated with a reduction in diabetes distress and improvement in quality of life in people with type 1 diabetes","volume":"26","author":"Reznik","year":"2024","journal-title":"Diabetes Obes Metabol"},{"issue":"18","key":"10.1016\/j.mcna.2025.11.010_bib75","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJMoa2415948","article-title":"A randomized trial of automated insulin delivery in type 2 diabetes","volume":"392","author":"Kudva","year":"2025","journal-title":"N Engl J Med"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712525001713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712525001713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T08:21:13Z","timestamp":1781857273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712525001713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":67,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0025712525001713"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2025.11.010","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perioperative Medication Management for Patients with Diabetes","name":"articletitle","label":"Article Title"},{"value":"Medical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcna.2025.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}